New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 11, 2014
04:55 EDTBAX, BAX, BAX, LH, LH, LH, ACT, ACT, ACT, HUM, HUM, HUM, UNH, UNH, UNH, THOR, THOR, THOR, HSIC, HSIC, HSIC, VRTX, VRTX, VRTX, CNC, CNC, CNC, BSX, BSX, BSX, HNT, HNT, HNTBarclays to hold a conference
Healthcare Conference is being held in Miami, Florida on March 11-13.
News For BAX;BSX;CNC;VRTX;HSIC;THOR;UNH;HUM;ACT;LH;HNT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
August 24, 2015
13:36 EDTVRTXBiotech correction presents some opportunities, says RBC Capital
RBC Capital analyst Michael Yee said he won't try to pick the short-term bottom in biotech, but contends that any macro weakness in China shouldn't have any major impact to financials or fundamentals for the sector given their minimal exposure there. If the market continues to be volatile, Yee recommends a focus on names with defensive characteristics, such as higher margins and free cash flow yield, naming Amgen (AMGN), Celgene (CELG) and Gilead (GILD) as some examples. The analyst adds that he likes Vertex (VRTX) on the pullback for "more aggressive" growth investors. Yee has Outperform ratings on all of the stocks mentioned above.
09:45 EDTTHOROn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:45 EDTLHLabCorp announces availability of VistaSeq Hereditary Cancer Panel
Subscribe for More Information
08:29 EDTTHORWilliam Blair to hold a field trip
Subscribe for More Information
06:39 EDTTHORThoratec downgraded to Market Perform from Outperform at Raymond James
Subscribe for More Information
06:19 EDTTHORThoratec downgraded to Market Perform from Outperform at Leerink
Leerink downgraded Thoratec (THOR) to Hold from Buy ahead of the closing of its merger transaction with St. Jude Medical (STJ), which is expected to close by year-end.
August 21, 2015
08:50 EDTTHORThoratec announces end of 'go shop' period in merger agreement with St. Jude
Subscribe for More Information
08:13 EDTUNHUnitedHealth has reached attractive entry point, says BMO Capital
Subscribe for More Information
August 20, 2015
08:03 EDTCNCCentene subsidiary wins statewide foster care contract
Subscribe for More Information
August 19, 2015
16:48 EDTBSXBoston Scientific announces FDA approval of Innova Self-Expanding Stent System
Subscribe for More Information
16:08 EDTHSICLeidos awarded $4.3B DoD contract
Leidos (LDOS) was awarded a prime contract by the Department of Defense, or DoD, to provide an off-the-shelf electronic health record solution, integration activities and deployment across the Military Health System. The contract, known as the Defense Healthcare Management System Modernization, or DHMSM, program, is an initiative designed to modernize the military's healthcare system in a meaningful way, enabling patients and clinicians to capture and share health data that can improve the continuity and quality of care for 9.6M active military, their families, and their beneficiaries. As the prime contractor, Leidos established a team of proven innovators and industry leaders to form the Leidos Partnership for Defense Health. Cerner (CERN), Accenture Federal Services (ACN) and Henry Schein (HSIC) form the core team, complemented with a broad range of large and small business teammates, vendors and suppliers who bring proven experience and expertise specific to both the commercial and DoD healthcare markets.
August 18, 2015
07:57 EDTUNHMagellan Iowa loss largely priced into shares, says Jefferies
Subscribe for More Information
August 17, 2015
16:12 EDTUNHMagellan drops after Iowa picks four others for Medicaid
Subscribe for More Information
15:57 EDTUNHUnitedHealth up 2.4% after being awarded Iowa healthcare contract
15:55 EDTUNHWellCare, Amerigroup, UnitedHealth, AmeriHealth awarded Iowa healthcare contract
Reference Link
06:22 EDTVRTXPiper's Tenthoff sees select biotech names outperforming in second half
Piper Jaffray analyst Edward Tenthoff expects drug launches, clinical data read-outs and potential partnerships to drive outperformance for select biotech names in the second half of 2015. Despite some recent profit-taking, 2015 has been another strong year for biotech stocks, Tenthoff tells investors in a research note. Names with important second half of the year catalysts include Vertex (VRTX), Regeneron (REGN), Seattle Genetics (SGEN), Exelixis (EXEL), Sarepta (SRPT), Novavax (NVAX), Arrowhead (ARWR), Array BioPharma (ARRY), Alnylam (ALNY), Genocea (GNCA), CymaBay (CBAY), Idera Pharmaceuticals (IDRA), Vitae Pharmaceuticals (VTAE).
August 14, 2015
17:24 EDTUNHUnitedHealth names Tom Roos as Chief Accounting Officer
Subscribe for More Information
16:44 EDTBAXThird Point gives quarterly update on stakes
NEW STAKES: Baxter (BAX), T-Mobile (TMUS), Sealed Air (SEE), Devon (DVN), and Perrigo (PRGO). INCREASED STAKES: SunEdison (SUNE), Dow Chemical (DOW), Mohawk (MHK), Yum! Brands (YUM), and IAC/InterActiveCorp (IACI). DECREASED STAKES: Ally Financial (ALLY), Amgen (AMGN), Sensata (ST), Masco (MAS), and Delta (DAL). LIQUIDATED STAKES: Dollar General (DG), McKesson (MCK), Edgewell Personal Care (EPC), Maxim (MXIM), and FleetCor (FLT).
13:03 EDTHUMOmega Advisors gives quarterly update on stakes, discloses stake in Google
Subscribe for More Information
09:01 EDTBAXBaxter, Water Street announce FDA approval for CEFAZOLIN 2 Gram Premix
Subscribe for More Information
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use